BigHat Biosciences raises $75M to advance BHB810, BHB299 and its AI protein-design platform after moving its first cancer therapeutic into the clinic.
bighatbiosciences.com is for sale on Spaceship. Secure checkout and quick transfer. See all purchase options. No hidden fees.
Peyton Greenside
Co-founder and CEO
Mark DePristo
Co-founder